Trial Search Results

Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant

The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive.

Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Other: Stanford Letter
  • Other: Interview
  • Other: Questionnaire Administration
  • Other: CA Advance Health Care Directive Form

Phase:

N/A

Eligibility


Inclusion Criteria:

   - All BMT patients at Stanford who are adults and give consent

Exclusion Criteria:

   - Less than 18 years of age

Ages Eligible for Study

18 Years - 100 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
VJ PERIYAKOIL, MD
650-493-5000
Recruiting